Axsome Therapeutics, Inc.

AXSM

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001579428

SEC filings (opens in a new tab)

In the last 90 days, Axsome Therapeutics, Inc. insiders filed 0 open-market purchases and 2 sales; 505 institutions reported holding it in 13F filings for Q2 2026, worth $9.34B in total; no superinvestor holds it.

Q3 2024 vs. Q2 2024

How the institutions holding Axsome Therapeutics, Inc. changed between Q2 2024 and Q3 2024.

All holders in Q3 2024 All holders in Q2 2024

13F holders of AXSM: Q2 2024 compared with Q3 2024
Measure	Q2 2024	Of which not filed for Q3 2024	Q3 2024	Change
Holders	257	3	280	+26
Shares	40.7M	3.30M	38.7M	+1.24M (+3.3%)
Value	$3.28B	$265.7M	$3.48B	+$463.3M (+15.4%)

3 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (48)

Institutions that held Axsome Therapeutics, Inc. at the end of Q3 2024 but not at the end of Q2 2024.

Institutions new to AXSM in Q3 2024
Institution	Shares	Value	% of portfolio
BlackRock, Inc.	3,398,379	$305.4M	0.01%
Iron Triangle Partners LP	252,266	$22.7M	3.19%
Cutter Capital Management, LP	105,767	$9.51M	2.81%
Lazard Asset Management LLC	85,932	$7.72M	0.01%
Balyasny Asset Management LLC	62,167	$5.59M	0.01%
Group One Trading, L.P.	50,141	$4.51M	0.18%
IFP Advisors, Inc	49,801	$4.48M	0.16%
SVB Capital Management, LLC	33,849	$3.04M	2.75%
Qube Research & Technologies Ltd	30,370	$2.73M	0.00%
ExodusPoint Capital Management, LP	29,479	$2.65M	0.03%
Panagora Asset Management Inc	27,231	$2.45M	0.01%
Wolverine Trading, LLC	14,050	$1.26M	0.03%
PDT Partners, LLC	11,701	$1.05M	0.09%
SG Americas Securities, LLC	11,553	$1.04M	0.00%
FORA Capital, LLC	11,058	$993.8K	0.12%
Intech Investment Management LLC	10,941	$983.3K	0.01%
Seven Eight Capital, LP	10,546	$947.8K	0.09%
Nicholas Investment Partners, LP	10,135	$910.8K	0.08%
Baird Financial Group, Inc.	10,118	$909.3K	0.00%
Caption Management, LLC	10,000	$898.7K	0.10%
Fred Alger Management, LLC	9,466	$850.7K	0.00%
B. Metzler seel. Sohn & Co. Holding AG	9,241	$830.5K	0.01%
Versor Investments LP	8,807	$791.5K	0.13%
Cynosure Management, LLC	7,930	$712.7K	0.10%
Landscape Capital Management, L.L.C.	6,513	$585.3K	0.06%
Values First Advisors, Inc.	6,322	$568.2K	0.31%
Captrust Financial Advisors	5,722	$514.2K	0.00%
Engineers Gate Manager LP	5,197	$467.1K	0.01%
PEAK6 Investments LLC	3,760	$337.9K	0.02%
Cerity Partners LLC	3,743	$336.4K	0.00%
Two Sigma Advisers, LP	3,400	$305.6K	0.00%
Sherbrooke Park Advisers LLC	3,348	$300.9K	0.07%
Whalen Wealth Management Inc.	2,628	$236.2K	0.17%
Acadian Asset Management LLC	2,408	$216.0K	0.00%
Xponance, Inc.	2,382	$214.1K	0.00%
Mackenzie Financial Corp	2,339	$210.2K	0.00%
NEOS Investment Management LLC	2,327	$209.1K	0.01%
Moors & Cabot, Inc.	2,230	$200.4K	0.01%
Danske Bank A/S	200	$18.0K	0.00%
Quest Partners LLC	82	$7.37K	0.00%
Sterling Capital Management LLC	37	$3.33K	0.00%
Bessemer Group Inc	30	$3.00K	0.00%
Geneos Wealth Management Inc.	23	$2.07K	0.00%
SRS Capital Advisors, Inc.	11	$989	0.00%
Wolff Wiese Magana LLC	10	$899	0.00%
Capital Performance Advisors LLP	10	$899	0.00%
Allspring Global Investments Holdings, LLC	9	$808	0.00%
GeoWealth Management, LLC	5	$449	0.00%

Sold out (22)

Institutions that held Axsome Therapeutics, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.

Institutions that sold out of AXSM in Q3 2024
Institution	Shares, Q2 2024	Value, Q2 2024
Vestal Point Capital, LP	300,000	$24.1M
MPM Oncology Impact Management LP	132,312	$10.7M
WMS Partners, LLC	40,711	$3.28M
SVB Financial Group	33,849	$2.72M
Susquehanna International Group, LLP	25,616	$2.06M
Jefferies Financial Group Inc.	15,859	$1.28M
XTX Topco Ltd	11,205	$902.0K
Bank of Montreal	10,531	$848.9K
Eisler Capital (US) LLC	10,285	$827.9K
Winton Group Ltd	8,823	$710.3K
Aquatic Capital Management LLC	5,200	$418.6K
Axq Capital, LP	4,892	$393.8K
Wedbush Securities Inc	4,818	$388.0K
Strategic Financial Concepts, LLC	26,010	$306.0K
Algert Global LLC	3,105	$250.0K
Flower City Capital	3,000	$241.5K
National Bank of Canada	610	$49.4K
Point72 Asia (Singapore) Pte. Ltd.	584	$47.0K
Meeder Asset Management Inc	47	$3.78K
Stephens Consulting, LLC	20	$1.61K
Atticus Wealth Management, LLC	15	$1.21K
Valley National Advisers Inc	20	$1.00K

Not filed for Q3 2024 yet (3)

Institutions that held Axsome Therapeutics, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding AXSM in Q2 2024 that haven't filed for Q3 2024
Institution	Shares, Q2 2024	Value, Q2 2024
BlackRock Inc.	3,299,991	$265.6M
JJJ Advisors Inc.	1,213	$97.6K
Institutional & Family Asset Management, LLC	5	$403